• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Timothy P. Hughes - Articles and news items

Novartis logo
Novartis logo

Longer-term Phase III data show Novartis drug Tasigna® continues to surpass Glivec® in slowing disease progression in patients

Industry news, News / 6 December 2010 / Novartis

with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)…


Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +